Trial Profile

Phase 2 clinical trial of DW2008 for treating asthma patients with COVID-19

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 May 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DW 2008 (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

13 May 2020 New trial record
06 May 2020 According to a DongWha Pharms media release, company is preparing for a COVID-19 phase 2 clinical trial in June after the prompt completion of efficacy evaluations in animals.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com